Drug
Zalutumumab
Zalutumumab: highest development phase Phase 3, developed by Genmab. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Genmab
Trials
| Drug | Phase | Indication |
|---|---|---|
| Zalutumumab NCT00382031 | Phase 3 | Head and Neck Cancer |
| zalutumumab NCT01449357 | Phase 2 | Non-small Cell Lung Cancer |
| Zalutumumab NCT00677924 | Phase 1/2 | Colorectal Cancer |
Latest
No recent events.
Follow Zalutumumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.